Thursday - March 5, 2026
FDA 510 Clearance Expands Bayer's MEDRAD MRXperion MR Injection System Support Across Diverse Range of MR Environments
March 05, 2026
WHIPPANY, New Jersey, March 5 -- Bayer USA, an enterprise with core competencies in the life science fields of health care and nutrition, issued the following news on March 4, 2026:

* * *

New FDA 510(k) Clearance Expands Bayer's MEDRAD(R) MRXperion MR Injection System Support Across Diverse Range of MR Environments

* Clearance reinforces Bayer's continued commitment to dependable, integrated radiology solutions

* Expanded Tesla compat . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products